home / stock / mnov / mnov news

MNOV News and Press, MediciNova Inc. From 11/20/23

Stock Information
Company Name: MediciNova Inc.
Stock Symbol: MNOV
Market: NASDAQ
Website: medicinova.com
Menu
MNOV MNOV Quote MNOV Short MNOV News MNOV Articles MNOV Message Board
Get MNOV Alerts

News, Short Squeeze, Breakout and More Instantly...
MNOV - 24/7 Market News Snapshot 20 Nov 2023

2023-11-20 10:00:41 ET DENVER, Colo., Nov. 20, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; Bruush Oral Care Inc (NASDAQ: BRSH), Cardio Diagnostics Holdings Inc (NASDAQ: CDIO), Neptune Wellness Solutio...
MNOV - MediciNova spikes on potential of lead asset in brain cancer

2023-11-20 06:44:56 ET More on MediciNova Biggest stock movers today: NuScale Power, Chegg and more MediciNova gains after nonclinical data for lead asset in lung injury Seeking Alpha’s Quant Rating on MediciNova Historical earnings data for MediciNova...

MNOV - Biggest stock movers today: NuScale Power, Chegg and more

2023-11-20 05:38:33 ET More on markets The Stock Market Rally Is Just Getting Started As Earnings Recession Ends Asia-Pacific stocks mixed as risk sentiment improves; PBoC maintains lending rates European markets mixed as investors continue to read Fed mood E...

MNOV - MediciNova Announces New Data and Results of a Phase 2 Clinical Trial of MN-166 (ibudilast) in Glioblastoma Presented at the 28th Annual Meeting of the Society for Neuro-Oncology

LA JOLLA, Calif., Nov. 19, 2023 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that MediciNova’s collaborator, Justin Lathia PhD, Co-...
MNOV - Expected US Company Earnings on Thursday, November 9th, 2023

Histogen Inc. (HSTO) is expected to report for Q3 2023 News Corporation (NWSA) is expected to report $0.13 for Q1 2024 TORM plc (TRMD) is expected to report for Q3 2023 Blink Charging Co. (BLNK) is expected to report $-0.47 for Q3 2023 Nuvalent Inc. (NUVL) is expected to report $-...

MNOV - Expected earnings - MediciNova Inc.

MediciNova Inc. (MNOV) is expected to report $-0.08 for Q3 2023

MNOV - MediciNova's Collaborator Initiates Clinical Development of a Gene Therapy Product for the Treatment of Phenylketonuria

LA JOLLA, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that its collaborator Genzyme Corporation, a subsidiary of Sa...
MNOV - MediciNova Receives a Notice of Allowance for a New Patent Covering the Combination of MN-166 (ibudilast) and Riluzole for the Treatment of Amyotrophic Lateral Sclerosis (ALS) in Canada

LA JOLLA, Calif., Oct. 10, 2023 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that it has received a Notice of Allowance from the Cana...

MNOV - MediciNova Receives Gene Therapy Milestone Payment

LA JOLLA, Calif., Oct. 04, 2023 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that it has received a milestone payment under MediciNova...

MNOV - MediciNova gains after nonclinical data for lead asset in lung injury

2023-09-28 06:48:04 ET More on MediciNova Seeking Alpha’s Quant Rating on MediciNova Historical earnings data for MediciNova Financial information for MediciNova For further details see: MediciNova gains after nonclinical data for lead asset in lun...
Previous 10 Next 10